Trial · NCT00530218
Adverse events226
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 226
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Haptoglobin | Blood and lymphatic system disorders | Patients With CMV Reactivation Detected | 1 | 32 | 1 |
| other | Haptoglobin | Blood and lymphatic system disorders | Patients Without CMV Reactivation Detected | 0 | 0 | 0 |
| other | Hemoglobin | Blood and lymphatic system disorders | Patients With CMV Reactivation Detected | 31 | 32 | 31 |
| other | Hemoglobin | Blood and lymphatic system disorders | Patients Without CMV Reactivation Detected | 0 | 0 | 0 |
| other | Hemolysis | Blood and lymphatic system disorders | Patients With CMV Reactivation Detected | 1 | 32 | 1 |
| other | Hemolysis | Blood and lymphatic system disorders | Patients Without CMV Reactivation Detected | 0 | 0 | 0 |
| other | Leukocytes | Blood and lymphatic system disorders | Patients With CMV Reactivation Detected | 22 | 32 | 22 |
| other | Leukocytes | Blood and lymphatic system disorders | Patients Without CMV Reactivation Detected | 0 | 0 | 0 |
| other | Lymphopenia | Blood and lymphatic system disorders | Patients With CMV Reactivation Detected | 2 | 32 | 2 |
| other | Lymphopenia | Blood and lymphatic system disorders | Patients Without CMV Reactivation Detected | 0 | 0 | 0 |
| other | Neutrophils/granulocytes | Blood and lymphatic system disorders | Patients With CMV Reactivation Detected | 12 | 32 | 12 |
| other | Neutrophils/granulocytes | Blood and lymphatic system disorders | Patients Without CMV Reactivation Detected | 0 | 0 | 0 |
| other | Platelets | Blood and lymphatic system disorders | Patients With CMV Reactivation Detected | 26 | 32 | 26 |
| other | Platelets | Blood and lymphatic system disorders | Patients Without CMV Reactivation Detected | 0 | 0 | 0 |
| other | pRBCs | Blood and lymphatic system disorders | Patients With CMV Reactivation Detected | 17 | 32 | 17 |
| other | pRBCs | Blood and lymphatic system disorders | Patients Without CMV Reactivation Detected | 0 | 0 | 0 |
| other | Acute graft versus host disease | Blood and lymphatic system disorders | Patients With CMV Reactivation Detected | 21 | 32 | 21 |
| other | Acute graft versus host disease | Blood and lymphatic system disorders | Patients Without CMV Reactivation Detected | 0 | 0 | 0 |
| other | Chronic graft versus host disease | Blood and lymphatic system disorders | Patients With CMV Reactivation Detected | 1 | 32 | 1 |
| other | Chronic graft versus host disease | Blood and lymphatic system disorders | Patients Without CMV Reactivation Detected | 0 | 0 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00530218/events